William Blair & Company’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-51,843
| Closed | -$75.7K | – | 1860 |
|
|
2022
Q4 | $75.7K | Hold |
51,843
| – | – | ﹤0.01% | 1520 |
|
|
2022
Q3 | $221K | Hold |
51,843
| – | – | ﹤0.01% | 1352 |
|
|
2022
Q2 | $201K | Hold |
51,843
| – | – | ﹤0.01% | 1417 |
|
|
2022
Q1 | $247K | Hold |
51,843
| – | – | ﹤0.01% | 1434 |
|
|
2021
Q4 | $189K | Hold |
51,843
| – | – | ﹤0.01% | 1597 |
|
|
2021
Q3 | $416K | Hold |
51,843
| – | – | ﹤0.01% | 1225 |
|
|
2021
Q2 | $588K | Hold |
51,843
| – | – | ﹤0.01% | 1094 |
|
|
2021
Q1 | $480K | Buy |
+51,843
| New | +$480K | ﹤0.01% | 1136 |
|